Skip to main content
Caplight Logo









Apollo Neuro

Apollo Neuro

Private
Pittsburgh, PennsylvaniaConsumer & Commercehttps://apolloneuro.com/

Last Round

Series A

Extension

Apr 15, 2024

Est. Valuation

$100M

Total Funding Raised

$31.8M

Company Overview

Apollo Neuro is a healthtech company that develops a wearable device using touch therapy to improve the body's resilience to stress, enabling better sleep, relaxation, and focus.

Sector

Consumer & Commerce

Verticals

Consumer Electronics, Medical Devices, Mental Health, Sports & Fitness, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

wearable devicehaptic feedbackstress managementheart rate variabilityHRVsleep improvementbiohackingnervous system regulationdirect-to-consumerDTCwellness technologydrug-free reliefpersonalized wellnesshealth wearablevibration therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apollo Neuro Comparables

Compare Apollo Neuro with similar companies based on industry and business-model similarity.

Apollo Neuro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sensate
85%
Neuvana
82%
NOWATCH
80%

Apollo Neuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionApr 15, 2024
Series AMar 17, 2022
SeedFeb 12, 2021
SeedJun 1, 2020

Key People

Founding team and executive leadership

David Rabin

Co-Founder Chief Medical Officer

Founding Team

Kathryn Fantauzzi

Co-Founder & CEO

Founding Team

Apollo Neuro Investors

Notable investors and investment history

Apollo Neuro investors
InvestorRounds
Pittsburgh Life Sciences GreenhouseSeed
Republic CapitalSeed
Innovation WorksSeed
Noetic FundSeries A
Satori CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 29, 2025

    Added Afro's Chicken, a restaurant, as a customer.

  • Oct 29, 2025

    Added Depeuterclub as a customer

Apollo Neuro Filings

Explore SEC and related filing metadata, where available.

Apollo Neuro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Apollo Neuro's valuation, stock price, and market status.

Is Apollo Neuro a public or private company?

Apollo Neuro is a private company.

What is the current stock price of Apollo Neuro?

Apollo Neuro is a private company with no public stock price. No recent secondary market data is available.

How much is Apollo Neuro worth (valuation)?

Apollo Neuro's valuation is estimated at $100.0M based on funding round data.

Can I buy Apollo Neuro stock?

Apollo Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Apollo Neuro's last funding round?

Apollo Neuro's most recent funding round was Series A on March 17, 2022.

Who are the main investors in Apollo Neuro?

Key investors in Apollo Neuro include Noetic Fund.

Will Apollo Neuro IPO soon?

No public IPO plans have been announced for Apollo Neuro.

How can I track Apollo Neuro secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apollo Neuro's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range16
Year Founded2017
Last FundingApr 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?